Triglimibrit 2mg Tablet
Manufacturer
Elbrit Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Key Information
Short Description
Triglimibrit 2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Dosage Form
Tablet
Introduction
Triglimibrit 2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Triglimibrit 2mg Tablet is to be taken empty stomach.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is unsafe to consume alcohol with Triglimibrit 2mg Tablet.
Breastfeeding Warning
Triglimibrit 2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy Warning
Triglimibrit 2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Triglimibrit 2mg Tablet is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Related Medicines
Gemer V2 Tablet
Vogli-GM 2 Tablet
Vogicare GM 2mg/500mg/0.2mg Tablet
Vobiwin Trio 2mg/500mg/0.2mg Tablet
Granmet MV 2mg/500mg/0.2mg Tablet
Glyvog gm 2mg Tablet
Fineglim MV 2mg/500mg/0.2mg Tablet
Voglyson GM Tablet
Carnezia VG 2mg/500mg/0.2mg Tablet
Ziglim-MV 2 Tablet
Frequently asked questions
What is Triglimibrit 2mg Tablet?
Triglimibrit 2mg Tablet is a combination medication that contains Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults by improving blood glucose levels when taken along with proper diet and regular exercise.
What are the possible side effects of Triglimibrit 2mg Tablet?
Common side effects associated with the use of Triglimibrit 2mg Tablet include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Are there any specific conditions in which Triglimibrit 2mg Tablet should not be taken?
The use of Triglimibrit 2mg Tablet is contraindicated in patients with a known allergy to any component or excipient, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while taking Triglimibrit 2mg Tablet?
It is not recommended to consume alcohol while taking Triglimibrit 2mg Tablet as it may lower blood sugar levels and increase the risk of lactic acidosis.
Can the use of Triglimibrit 2mg Tablet cause hypoglycemia?
Yes, the use of Triglimibrit 2mg Tablet can lead to hypoglycemia (low blood sugar level), particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular monitoring of blood glucose levels and having glucose tablets or honey readily available are essential.
What are the instructions for the storage and disposal of Triglimibrit 2mg Tablet?
Store Triglimibrit 2mg Tablet in its original packet or container, tightly closed. Dispose of unused medication properly to prevent accidental consumption by pets, children, and other individuals.
